Scilex Holding (NASDAQ:SCLX – Get Rating) was down 6.8% during trading on Tuesday . The company traded as low as $7.70 and last traded at $8.10. Approximately 87,227 shares were traded during mid-day trading, a decline of 83% from the average daily volume of 509,121 shares. The stock had previously closed at $8.69.
Scilex Stock Down 9.8 %
The stock has a 50-day moving average of $5.36.
About Scilex
(Get Rating)
Scilex Holding Company, a biopharmaceutical company, focuses on developing and commercializing non-opioid management products for the treatment of acute and chronic pain. Its commercial product is ZTlido 1.8%, a prescription lidocaine topical product for the relief of neuropathic pain related with post-herpetic neuralgia, which is a form of post-shingles nerve pain.
Featured Articles
- Get a free copy of the StockNews.com research report on Scilex (SCLX)
- Will Caterpillar Dig Its Way To Another Buying Opportunity?
- United Parcel Service Delivers Shareholder Value
- Will McDonald's Stock Hit an All-Time HIgh After Earnings?
- Carvana Is Up 39.28% In One Week: Is It The Newest Meme Stock?
- Whirlpool Corporation: High-Yield Value Spins Back Into Style
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.